HomeC26 • FRA
add
CellaVision AB
Previous close
€19.52
Day range
€19.62 - €20.10
Year range
€11.22 - €25.95
Market cap
5.51B SEK
Avg Volume
13.00
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
(SEK) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | 178.66M | 6.41% |
Operating expense | 82.89M | 6.06% |
Net income | 31.11M | 19.84% |
Net profit margin | 17.42 | 12.68% |
Earnings per share | 1.30 | 19.27% |
EBITDA | 46.78M | 12.86% |
Effective tax rate | 20.05% | — |
Balance Sheet
Total assets
Total liabilities
(SEK) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 137.66M | 74.63% |
Total assets | 983.84M | 9.99% |
Total liabilities | 215.98M | -0.27% |
Total equity | 767.86M | — |
Shares outstanding | 23.85M | — |
Price to book | 0.61 | — |
Return on assets | 9.89% | — |
Return on capital | 12.09% | — |
Cash Flow
Net change in cash
(SEK) | Sep 2024info | Y/Y change |
---|---|---|
Net income | 31.11M | 19.84% |
Cash from operations | 40.88M | -44.00% |
Cash from investing | -15.60M | 14.48% |
Cash from financing | -9.49M | 9.77% |
Net change in cash | 15.40M | -64.95% |
Free cash flow | 16.24M | -66.68% |
About
Founded
1994
Website
Employees
228